Skip to Content

Boston Scientific Corporation

Corporate Governance / Derivative

  • Date:
  • 3/10/2026
  • Company Name:
  • Boston Scientific Corporation
  • Stock Symbol:
  • BSX
  • Class Period:
  • FROM 7/23/2025 TO 2/3/2026
  • Status:
  • Investigating

Case Finder

Locate any case using the tools below.

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Boston Scientific Corporation (NYSE:BSX) on behalf of long-term stockholders following a class action complaint that was filed against Boston Scientific on March 5, 2026 with a Class Period from July 23, 2025, to February 3, 2026. Our investigation concerns whether the board of directors of Boston Scientific have breached their fiduciary duties to the company.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Boston Scientific’s U.S. EP segment’s growth rate was unsustainable and was approaching an earlier tipping point than the market was anticipating; (2) the Company was experiencing new competition entrants that were sapping Boston Scientific’s U.S. Electrophysiology market share and thus limiting the Company’s growth potential; (3) as a result, Defendants’ repeated statements of confidence in the U.S. EP division’s growth trajectory, including repeatedly elevated full-year guidance metrics, were materially misleading; and (4) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
 

If you are a long-term stockholder of Boston Scientific, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or  Melissa Fortunato by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
Contact Instructions
Please contact Brandon Walker or  Melissa Fortunato by email at investigations@bespc.com with any questions.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Boston Scientific Corporation . BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: